SAN
DIEGO, July 17, 2024 /PRNewswire/ -- Aspen
Neuroscience, Inc., a clinical-stage private biotechnology company
developing personalized regenerative therapies, announced today
that president and CEO Damien McDevitt, PhD, will participate
in a virtual fireside chat at the 2024 Raymond James Biotech
Private Company Showcase on Thursday, July
18 at 11 a.m. PT /
2 p.m. ET.
About Aspen Neuroscience
Aspen Neuroscience, Inc., headquartered in San Diego, is dedicated to autologous
regenerative medicine. The company's patient-derived iPSC platform
is used to create personalized therapies, a crucial step in
addressing diseases with high unmet medical needs, starting with
autologous neuron replacement for Parkinson's disease.
Aspen combines cell biology with the latest machine learning and
genomic approaches to investigate patient-specific, restorative
cell treatments. The company's unwavering commitment to quality is
evident in its best-in-class platform to create and optimize
pluripotent-derived cell therapies, which includes in-house
bioinformatics, manufacturing, and quality control.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aspen-neuroscience-to-present-at-2024-raymond-james-biotech-private-company-showcase-july-18-302198885.html
SOURCE Aspen Neuroscience, Inc.